We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Nekrobiotický xantogranulom asociovaný s monoklonální gamapatií: popis případu a přehled léčebných možností.
- Authors
Král, Z.; Krejčí, M.; Kynclová, J.; Řehák, Z.; Koukalová, R.; Skorkovská, Š.; Pour, L.; Adam, Z.
- Abstract
Necrobiotic xanthogranuloma is an uncommon non-Langerhans cell histiocytosis involving skin and extra cutaneous tissues. Necrobiotic xanthogranuloma is most frequently associated with MGUS, myeloma and may also occur in other lymphoproliferative disorders. Its pathogenesis remains unclear. Necrobiotic xanthogranuloma is usually a chronic and slowly progressive disease. Several treatments have been proposed and have yielded variable results. The aim of this case report and systematic review is to summarize all reported treatments of necrobiotic xanthogranuloma of the skin, with or without underlying malignant conditions. Treatment options include corticosteroids, thalidomide, high-dose intravenous immunoglobulins (IVIG), chlorambucil, cyclophosphamide, fludarabine, rituximab, melphalan, infliximab, cladribine, laser therapy, radiotherapy and other possibilities. The treatment options are at most only partially effective; the best response is achieved with IVIG therapy. In our case, treatment with cyclophosphamide, dexamethasone and bortesomib did not lead to any significant response. We then used IVIG and electron beam irradiation achieving a partial response and stabilization of this rare disease..
- Publication
Transfusiology & Haematology Today / Transfuze a Hematologie Dnes, 2020, Vol 26, Issue 3, p310
- ISSN
1213-5763
- Publication type
Article